Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

Name: Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
License: Public Domain

Boehringer Ingelheim

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 463671
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.